Thymosin Alpha-1 — Thymic peptide — immunomodulator
Enhances T-cell maturation and function (CD4+, CD8+, NK cells), promotes dendritic cell maturation, modulates TLR signaling, and restores immune balance. Anti-inflammatory and anti-tumor immune surveillance enhancement.
Overview
This page is part of Hormonaly's evidence-graded compound library. All clinical claims are linked to peer-reviewed sources via our dual-layer citation verification pipeline.
Compound Class
Thymic peptide — immunomodulator
Mechanism of Action
Enhances T-cell maturation and function (CD4+, CD8+, NK cells), promotes dendritic cell maturation, modulates TLR signaling, and restores immune balance. Anti-inflammatory and anti-tumor immune surveillance enhancement.
Regulatory Status
Not FDA approved in US; FDA Orphan Drug designation for hepatocellular carcinoma
Evidence Level
High — approved in 35+ countries; extensive Phase 3 data in hepatitis and cancer